Literature DB >> 1776122

Management of posterior uveal melanoma.

J A Shields1, C L Shields, L A Donoso.   

Abstract

In recent years, there have been a number of advances in the diagnosis and management of patients with malignant melanoma of the posterior uvea (ciliary body and choroid). This review provides a brief update on the current status of diagnostic modalities, such as fluorescein angiography, ultrasonography, computed tomography, magnetic resonance imaging, fine needle aspiration biopsy, and the radioactive phosphorus uptake test. Following that is a more detailed review of the current controversy regarding the natural course of uveal melanomas and the available therapeutic modalities. Current indications, techniques, complications, and results are provided for various forms of management, such as observation, laser photocoagulation, plaque radiotherapy, charged particle radiotherapy, local tumor resection, enucleation, and orbital exenteration.

Entities:  

Mesh:

Year:  1991        PMID: 1776122     DOI: 10.1016/0039-6257(91)90001-v

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  26 in total

1.  Extrascleral extension of a choroidal melanoma after argon photocoagulation and transpupillary thermotherapy.

Authors:  T Tsai; J M O'Brien; R Engstrom; B R Straatsma
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

Review 2.  Uveal melanomas in black patients: a case series and comparative review.

Authors:  B A Phillpotts; R J Sanders; J A Shields; J D Griffiths; J A Augsburger; C L Shields
Journal:  J Natl Med Assoc       Date:  1995-09       Impact factor: 1.798

3.  Metastases to the conjunctiva.

Authors:  C Wood
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

4.  Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.

Authors:  S N Chia; H B Smith; H M Hammer; E G Kemp
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

5.  Iatrogenic choroidal neovascularisation following argon laser photocoagulation for choroidal malignant melanoma.

Authors:  Z I Currie; I G Rennie; J F Talbot
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

6.  A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.

Authors:  S R Elshaw; K Sisley; N Cross; A K Murray; S M MacNeil; M Wagner; C E Nichols; I G Rennie
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

7.  Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma.

Authors:  H E Grossniklaus
Journal:  Trans Am Ophthalmol Soc       Date:  1998

8.  Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays.

Authors:  Mona Pache; Katharina Glatz; Doris Bösch; Stephan Dirnhofer; Martina Mirlacher; Ronald Simon; Peter Schraml; Alex Rufle; Josef Flammer; Guido Sauter; Peter Meyer
Journal:  Virchows Arch       Date:  2003-09-26       Impact factor: 4.064

9.  Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival.

Authors:  P De Potter; C L Shields; J A Shields; J R Cater; D J Tardio
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

10.  Internal resection of posterior uveal melanomas.

Authors:  P J Kertes; J C Johnson; G A Peyman
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.